BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry

Regulatory 1 min
May 7, 2020

COVID-19 presents an unprecedented challenge to the global life sciences industry.  Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located.  This update aims to provide guidance on the responses of EU and Asia-Pac regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.

Today we release the latest in our series, focusing on Public Procurement, watch this space for the others coming very soon!

  • COVID-19: Legislation Tracker for Medical Devices, read here
  • COVID-19: Legislation Tracker for Clinical Trials, read here
  • COVID-19: Legislation Tracker for Public Procurement, read here
  • COVID-19: Legislation Tracker for State Use/Compulsory Licensing, read here

Related articles

Investing in the future of cannabis in the UK – lessons from the German model
The excitement around the potential for the UK cannabis market – medicinal and nutritional – to continue...
Transfers of value to “influencers”: new disclosure obligation for companies in the health sector
The list of beneficiaries of transfers of value subject to compulsory disclosure in the French public...
Increased Leeway for Cooperation between Pharma and Medical Equipment Companies during the Covid-19 Crisis
Competition rules are aimed at safeguarding healthy competition between companies. For more than half...
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.